Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 56, Issue 65, 2001, Pages 14-20

  Bachert, C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Allergic cascade; Allergic rhinitis; Congestion; Desloratadine

Indexed keywords

ALLERGEN; CETIRIZINE; DECONGESTIVE AGENT; DESLORATADINE; EBASTINE; FEXOFENADINE; LORATADINE; MEPYRAMINE; MIZOLASTINE; TERFENADINE;

ALLERGIC REACTION; ALLERGIC RHINITIS; DRUG EFFICACY; HUMAN; MEDIATOR RELEASE; NOSE CONGESTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEASONAL VARIATION; SYMPTOM;

CHEMOTAXIS, LEUKOCYTE; CHOLINERGIC ANTAGONISTS; EOSINOPHILS; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; PLATELET ACTIVATING FACTOR; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035131070     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Mucosal inflammation and allergic rhinitis
2. Mechanisms of mucosal inflammation in the nose and lungs
3. Pathophysiology of allergic rhinitis
4. Basophils, mast cells and eosinophils and their precursors in allergic rhinitis
5. Proinflammatory cytokines in allergic rhinitis
6. γδ T cells in allergic airway diseases
7. Allergy and hypersensitivity
8. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy
9. The effect of IL-4 on human nasal mucosal responses
10. 1 receptors
11. 1-antagonist, desethoxycarbonyl-loratadine
12. In vitro inhibition, by loratadine and descarboxyethoxyloratadine, of histamine release from human basophils, and of histamine release and intracellular calcium fluxes in rat basophilic leukemia cells (RBL-2H3)
13. 2+ levels and leukotriene release: Novel mechanisms of action independent of the anti-histamine activity
14. 1 receptor and in human bronchial smooth muscle cells (HBSMC)
15. Loratadine and desethoxylcarbonylloratadine inhibit the immunological release of mediators from human Fc epsilon RI + cells
16. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells
17. 1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines
18. Inhibitory activity of loratadine and descarboxyethoxyloratadine on histamine-induced activation of endothelial cells
19. Loratadine (L) reduces RANTES release by an epithelial cell line
20. Desloratadine attenuation of eosinophil chemotaxis, adhesion, and superoxide generation
21. Desloratadine 5 mg once daily reduces nasal congestion in patients with seasonal allergic rhinitis
22. Desloratadine is effective at relieving nasal congestion, as demonstrated in three placebo-controlled trials in patients with seasonal allergic rhinitis
23. Desloratadine relieved nasal congestion in patients with seasonal allergic rhinitis and concurrent asthma
24. Decongestant effects of desloratadine in patients with seasonal allergic rhinitis
25. Onset and duration of action of desloratadine
26. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis
27. Once-daily cetirizine effective in the treatment of seasonal allergic rhinitis in children aged 6 to 11 years: A randomized, double-blind, placebo-controlled study
28. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis
29. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis
30. The prevalence of allergic rhinitis and nasal symptoms in Nottingham
31. Epidemiology of seasonal and perennial rhinitis: Clinical presentation and medical history
32. Nasal obstruction as a risk factor for sleep-disordered breathing
33. Safety of inhaled and intranasal corticosteroids: Lessons for the new millennium
34. Allergic rhinitis and asthma: How important is the link?